Clifford Wong

816 total citations
13 papers, 360 citations indexed

About

Clifford Wong is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Clifford Wong has authored 13 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Hepatology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Clifford Wong's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Clifford Wong is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Clifford Wong collaborates with scholars based in United States, Taiwan and China. Clifford Wong's co-authors include Mindie H. Nguyen, An K. Le, Huy N. Trinh, Christopher K. Wong, Jian Zhang, Hwai‐I Yang, Linda Henry, Ramsey Cheung, Nghia Nguyen and Michael H. Le and has published in prestigious journals such as The Journal of Infectious Diseases, Clinical Pharmacology & Therapeutics and BMC Public Health.

In The Last Decade

Clifford Wong

13 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clifford Wong United States	10	307	276	25	24	12	13	360
V. Boccaccio Italy	9	200 0.7×	183 0.7×	9 0.4×	14 0.6×	8 0.7×	14	243
C Glaubke Germany	3	264 0.9×	285 1.0×	6 0.2×	14 0.6×	4 0.3×	3	313
Valentina Liakina Lithuania	8	98 0.3×	83 0.3×	22 0.9×	8 0.3×	13 1.1×	27	159
Sakura Kirino Japan	10	248 0.8×	218 0.8×	11 0.4×	3 0.1×	18 1.5×	23	285
Aimilia Karampatou Italy	3	106 0.3×	115 0.4×	9 0.4×	11 0.5×	10 0.8×	3	154
Tony Carlsson Sweden	6	281 0.9×	284 1.0×	18 0.7×	4 0.2×	10 0.8×	7	304
Dietmar M. Klass Germany	5	219 0.7×	201 0.7×	8 0.3×	8 0.3×	14 1.2×	11	274
Hasmik Ghazinian Australia	3	101 0.3×	104 0.4×	5 0.2×	3 0.1×	13 1.1×	3	143
Costanza Sbreglia Italy	9	63 0.2×	60 0.2×	14 0.6×	50 2.1×	30 2.5×	20	157

Countries citing papers authored by Clifford Wong

Since Specialization

Citations

This map shows the geographic impact of Clifford Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford Wong more than expected).

Fields of papers citing papers by Clifford Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford Wong. The network helps show where Clifford Wong may publish in the future.

Co-authorship network of co-authors of Clifford Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford Wong. A scholar is included among the top collaborators of Clifford Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford Wong. Clifford Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wong, Clifford, et al.. (2023). Gender differences in the relationships between meaning in life, mental health status and digital media use during Covid-19. BMC Public Health. 23(1). 1770–1770. 6 indexed citations

Huang, Daniel Q., Dong Hyun Lee, Michael H. Le, et al.. (2022). Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B. Digestive Diseases. 41(1). 115–123. 12 indexed citations

Huang, Daniel Q., Xiaohe Li, Michael H. Le, et al.. (2021). Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase. Clinical Gastroenterology and Hepatology. 20(8). 1803–1812.e5. 64 indexed citations

Tseng, Tai‐Chung, Jonggi Choi, Mindie H. Nguyen, et al.. (2021). One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. Hepatology International. 15(1). 105–113. 8 indexed citations

Le, An K., Hwai‐I Yang, Ming‐Lun Yeh, et al.. (2020). Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B. The Journal of Infectious Diseases. 223(1). 139–146. 4 indexed citations

Li, Jie, Hwai‐I Yang, Ming‐Lun Yeh, et al.. (2020). Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B. The Journal of Infectious Diseases. 224(2). 294–302. 62 indexed citations

Wei, Mike, An K. Le, Matthew S. Chang, et al.. (2019). Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B. Journal of Medical Virology. 91(7). 1288–1294. 18 indexed citations

Nguyen, Vy H., An K. Le, Huy N. Trinh, et al.. (2018). Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices. Clinical Gastroenterology and Hepatology. 17(5). 957–967.e7. 27 indexed citations

Liu, Anne, An K. Le, Jian Zhang, et al.. (2018). Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000–2015. Clinical and Translational Gastroenterology. 9(3). e141–e141. 37 indexed citations

10.

Nguyen, Mindie H., Hwai‐I Yang, An K. Le, et al.. (2018). Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study. The Journal of Infectious Diseases. 219(1). 10–18. 72 indexed citations

11.

Jackson, Sam, Albert F. Candia, Stephen Delaney, et al.. (2017). First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated. Clinical Pharmacology & Therapeutics. 104(2). 335–345. 22 indexed citations

12.

Nguyen, Nghia, Huy N. Trinh, Christopher K. Wong, et al.. (2015). Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. Digestive Diseases and Sciences. 61(2). 618–625. 14 indexed citations

13.

Wong, Clifford, Nitish R. Mahapatra, Payam Mahboubi, et al.. (2003). The angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse. Physiological Genomics. 14(1). 83–93. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact